Temitayo Omowumi Alegbejo Price
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Temitayo Omowumi Alegbejo Price has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Flavio da Silva Emery
University of São Paulo
9 shared publications - Wim Dehaen
Sustainable Chemistry for Metals and Molecules, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Leuven, Belgium
5 shared publications - Jose Luis Medina Franco
Universidad Nacional Autónoma de México
3 shared publications - Alexandre Bizzotto Carvalho
São Carlos Institute of Physics
2 shared publications - Ana L. Chávez-Hernández
Universidad Nacional Autónoma de México
2 shared publications - Carolina Horta Andrade
Universidade Federal de Goiás
2 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by Wiley in ChemMedChem
- Vol. 21 (20) , e70505
Synthesis of Nitrogen‐Containing Heterocyclic Scaffolds and Applications in Scaffold Hopping: Development of an Aripiprazole Analog
Heteroaromatic ring systems play a crucial role in drug development because they modulate physicochemical properties and expand the range of molecular interactions compared to non‐heterocyclic aromatic rings. They are also widely represented among approved drugs. Among heteroatoms, nitrogen is the most prevalent in the diverse scaffold space of heterocyclic drugs, including those generated by fragment‐based drug discovery approach. In this work, we show the synthesis of a set of novel or underexplored nitrogen heterocyclic fragments, obtained in three to five steps in moderate yields. In total, 12 fused [6,6] saturated/unsaturated bicycles were synthesized, which fulfill the general rule of fragment‐like compounds. These heterocycles increased the fragment space of the CRAFT library and showed potential application in scaffold‐hopping strategies for drug design. As a proof of concept, 2,6‐naphthyridin‐3‐ol 2 was used to replace the 7‐hydroxy‐3,4‐dihydroquinolin‐2(1 H )‐one core of aripiprazole 41 , generating 3‐(4‐(4‐(2,3‐dichlorophenyl)piperazin‐1‐yl)butoxy)‐2,6‐naphthyridine 40, that effectively blocked cocaine‐induced hyperactivity in rodents at 20 mg/kg without inducing catalepsy, displaying a pharmacological profile similar to aripiprazole and demonstrating promising antipsychotic potential.
- 25 October 2026
- Published by Wiley in ChemMedChem
- Vol. 21 (20) , e70505
Open AccessSynthesis of Nitrogen‐Containing Heterocyclic Scaffolds and Applications in Scaffold Hopping: Development of an Aripiprazole Analog
Heteroaromatic ring systems play a crucial role in drug development because they modulate physicochemical properties and expand the range of molecular interactions compared to non‐heterocyclic aromatic rings. They are also widely represented among approved drugs. Among heteroatoms, nitrogen is the most prevalent in the diverse scaffold space of heterocyclic drugs, including those generated by fragment‐based drug discovery approach. In this work, we show the synthesis of a set of novel or underexplored nitrogen heterocyclic fragments, obtained in three to five steps in moderate yields. In total, 12 fused [6,6] saturated/unsaturated bicycles were synthesized, which fulfill the general rule of fragment‐like compounds. These heterocycles increased the fragment space of the CRAFT library and showed potential application in scaffold‐hopping strategies for drug design. As a proof of concept, 2,6‐naphthyridin‐3‐ol 2 was used to replace the 7‐hydroxy‐3,4‐dihydroquinolin‐2(1 H )‐one core of aripiprazole 41 , generating 3‐(4‐(4‐(2,3‐dichlorophenyl)piperazin‐1‐yl)butoxy)‐2,6‐naphthyridine 40, that effectively blocked cocaine‐induced hyperactivity in rodents at 20 mg/kg without inducing catalepsy, displaying a pharmacological profile similar to aripiprazole and demonstrating promising antipsychotic potential.
- Open Access
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Modulated Aromaticity in a Pyrimido[1,6-b]indazole Scaffold Revealed by Integrated NMR, DFT, and Single-Crystal X-ray Analysis
Pyrimido[1,6-b]indazole represents a recently reported fused heterocyclic framework whose electronic structure remains unexplored. In this work, we present a comprehensive structural and electronic investigation of this scaffold through an integrated experimental–theoretical approach combining NMR spectroscopy, density functional theory (DFT) calculations, and single-crystal X-ray diffraction. Detailed 1H and 13C NMR analyses, supported by GIAO–DFT calculations, enabled reliable spectral assignment and revealed efficient long-range electronic communication across the rigid π-conjugated system. Single-crystal X-ray diffraction confirmed a highly planar architecture, while bond metric analysis disclosed pronounced differentiation of C–N and C–C bond lengths throughout the fused core. Quantitative correlation between experimental and computed geometrical parameters demonstrated excellent agreement, validating the computational model for probing subtle electronic effects. Comparative analysis with related aromatic systems highlights significant bond-length alternation and electronic asymmetry induced by heterocycle fusion and heteroatom incorporation. These features provide consistent evidence for a non-uniform distribution of π-electron density, supporting the description of modulated aromaticity within the tricyclic framework. In the solid state, intermolecular organization is governed by π–π stacking and dispersion-driven contacts, as supported by Hirshfeld surface analysis. Together, these findings establish pyrimido[1,6-b]indazole as a representative model for investigating electronic polarization in fused heteroaromatic systems, offering new insights into structure–property relationships beyond classical aromaticity descriptions.
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessModulated Aromaticity in a Pyrimido[1,6-b]indazole Scaffold Revealed by Integrated NMR, DFT, and Single-Crystal X-ray Analysis
Pyrimido[1,6-b]indazole represents a recently reported fused heterocyclic framework whose electronic structure remains unexplored. In this work, we present a comprehensive structural and electronic investigation of this scaffold through an integrated experimental–theoretical approach combining NMR spectroscopy, density functional theory (DFT) calculations, and single-crystal X-ray diffraction. Detailed 1H and 13C NMR analyses, supported by GIAO–DFT calculations, enabled reliable spectral assignment and revealed efficient long-range electronic communication across the rigid π-conjugated system. Single-crystal X-ray diffraction confirmed a highly planar architecture, while bond metric analysis disclosed pronounced differentiation of C–N and C–C bond lengths throughout the fused core. Quantitative correlation between experimental and computed geometrical parameters demonstrated excellent agreement, validating the computational model for probing subtle electronic effects. Comparative analysis with related aromatic systems highlights significant bond-length alternation and electronic asymmetry induced by heterocycle fusion and heteroatom incorporation. These features provide consistent evidence for a non-uniform distribution of π-electron density, supporting the description of modulated aromaticity within the tricyclic framework. In the solid state, intermolecular organization is governed by π–π stacking and dispersion-driven contacts, as supported by Hirshfeld surface analysis. Together, these findings establish pyrimido[1,6-b]indazole as a representative model for investigating electronic polarization in fused heteroaromatic systems, offering new insights into structure–property relationships beyond classical aromaticity descriptions.
- Open Access
- 26 May 2026
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (6) , 1398-1406
5-Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure–Activity Relationship and Nitroreductase Activation
Neglected tropical diseases such as Chagas disease remain poorly served by current chemotherapies due to toxicity and the emergence of drug resistance. Nitroaromatic compounds represent an established antitrypanosomal strategy, relying on bioactivation by Trypanosoma type I nitroreductases. In this study, a fragment-based design approach was applied to the nitroaromatic drugs nifurtimox and benznidazole to generate a novel hybrid scaffold, (E)-N-benzyl-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (1). A series of twenty-two analogues was synthesized by modifying the benzylamine substituent and evaluated for antitrypanosomal activity and susceptibility to nitroreductase I-mediated activation and early ADME properties. Among the series, (E)-N-(4-methylbenzyl)-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (3) and (1) exhibited potent anti-T. cruzi activity (0.14 μM and 0.23 μM), anti-T. b. brucei activity (0.59 ± 0.03 μM and 29.3 ± 15.6 μM), and anti-T. b. rhodesiense (0.87 ± 0.8 μM and 7.44 ± 1.00 μM) in parasite cultures. These findings identify this chemotype as a promising starting point for the further development of nitroreductase-activated therapeutics for Trypanosomiasis disease.
- 26 May 2026
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (6) , 1398-1406
Open Access5-Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure–Activity Relationship and Nitroreductase Activation
Neglected tropical diseases such as Chagas disease remain poorly served by current chemotherapies due to toxicity and the emergence of drug resistance. Nitroaromatic compounds represent an established antitrypanosomal strategy, relying on bioactivation by Trypanosoma type I nitroreductases. In this study, a fragment-based design approach was applied to the nitroaromatic drugs nifurtimox and benznidazole to generate a novel hybrid scaffold, (E)-N-benzyl-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (1). A series of twenty-two analogues was synthesized by modifying the benzylamine substituent and evaluated for antitrypanosomal activity and susceptibility to nitroreductase I-mediated activation and early ADME properties. Among the series, (E)-N-(4-methylbenzyl)-2-((5-nitrofuran-2-yl)methylene)hydrazine-1-carboxamide (3) and (1) exhibited potent anti-T. cruzi activity (0.14 μM and 0.23 μM), anti-T. b. brucei activity (0.59 ± 0.03 μM and 29.3 ± 15.6 μM), and anti-T. b. rhodesiense (0.87 ± 0.8 μM and 7.44 ± 1.00 μM) in parasite cultures. These findings identify this chemotype as a promising starting point for the further development of nitroreductase-activated therapeutics for Trypanosomiasis disease.
- Open Access
- 21 March 2026
- Published by Elsevier in SSRN Electronic Journal
Modulated Aromaticity in a Novel Fluorescent Pyrimido[1,6-b]indazole Scaffold Revealed by Integrated NMR, DFT, and Single-Crystal X-ray Analysis
A novel fluorescent pyrimido[1,6-b]indazole scaffold is reported and structurally elucidated through an integrated experimental–theoretical approach. The heterotricyclic framework was accessed via a one-pot 6-endo-dig cyclization and comprehensively characterized by 1H/13C NMR spectroscopy, high-resolution mass spectrometry, density functional theory (DFT) calculations, and single-crystal X-ray diffraction. Detailed NMR analysis supported by GIAO–DFT chemical shift calculations enabled reliable assignment of the fused aromatic system, revealing efficient electronic communication across the rigid π-conjugated core. Single-crystal X-ray diffraction confirmed a predominantly planar architecture, pronounced C–N bond differentiation (1.293–1.392 Å), and conjugative interaction between the ester substituent and the heteroaromatic framework. Quantitative linear regression analyses between experimental and DFT-optimized bond lengths and bond angles (r ≈ 0.995–0.996) demonstrate excellent agreement, validating the computational model for probing electronic polarization within the scaffold. Comparative evaluation with benzene, indazole, and pyrimidine highlights enhanced bond-length alternation and electronic asymmetry arising from annulation and heteroatom incorporation, supporting a description of modulated aromaticity. In the solid state, molecules assemble through slipped π–π stacking interactions, further reinforcing structural rigidity. Together, these results provide a coherent structural–electronic picture of this uncommon heterocycle and establish a robust platform for future functionalization and photophysical investigations.
- 21 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessModulated Aromaticity in a Novel Fluorescent Pyrimido[1,6-b]indazole Scaffold Revealed by Integrated NMR, DFT, and Single-Crystal X-ray Analysis
A novel fluorescent pyrimido[1,6-b]indazole scaffold is reported and structurally elucidated through an integrated experimental–theoretical approach. The heterotricyclic framework was accessed via a one-pot 6-endo-dig cyclization and comprehensively characterized by 1H/13C NMR spectroscopy, high-resolution mass spectrometry, density functional theory (DFT) calculations, and single-crystal X-ray diffraction. Detailed NMR analysis supported by GIAO–DFT chemical shift calculations enabled reliable assignment of the fused aromatic system, revealing efficient electronic communication across the rigid π-conjugated core. Single-crystal X-ray diffraction confirmed a predominantly planar architecture, pronounced C–N bond differentiation (1.293–1.392 Å), and conjugative interaction between the ester substituent and the heteroaromatic framework. Quantitative linear regression analyses between experimental and DFT-optimized bond lengths and bond angles (r ≈ 0.995–0.996) demonstrate excellent agreement, validating the computational model for probing electronic polarization within the scaffold. Comparative evaluation with benzene, indazole, and pyrimidine highlights enhanced bond-length alternation and electronic asymmetry arising from annulation and heteroatom incorporation, supporting a description of modulated aromaticity. In the solid state, molecules assemble through slipped π–π stacking interactions, further reinforcing structural rigidity. Together, these results provide a coherent structural–electronic picture of this uncommon heterocycle and establish a robust platform for future functionalization and photophysical investigations.
- Open Access
- 14 July 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (18) , 18869-18884
Barbituric Acid Derivatives as Covalent Inhibitors of Leishmania braziliensis Dihydroorotate Dehydrogenase
Covalent drug design applied to parasite proteins enables selective therapies by targeting nucleophilic residues of macromolecules. We present the first covalent inhibitors of Leishmania braziliensis dihydroorotate dehydrogenase (LbDHODH), a key enzyme in pyrimidine biosynthesis with a reactive cysteine (Cys131) in its active site. From barbituric acid derivatives, we discovered 2i as a LbDHODH inhibitor with leishmanicidal activity, exhibiting an IC50 of 0.5 ± 0.1 μM, a Kinact/KI of 767 M-1s-1, no inhibition of the human ortholog, and an EC50 of 11 ± 5 μM in L. braziliensis promastigotes, with no cytotoxicity in THP-1 cells and good passive permeability. X-ray crystallography confirms covalent bond formation with Cys131 and reveals active-site rearrangements. These findings support the proposed covalent inhibition mechanism and provide structural insights for further optimization. Our study validates LbDHODH as a promising target for leishmaniasis therapy and highlights the potential of covalent inhibition in antiparasitic drug discovery.
- 14 July 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (18) , 18869-18884
Open AccessBarbituric Acid Derivatives as Covalent Inhibitors of Leishmania braziliensis Dihydroorotate Dehydrogenase
Covalent drug design applied to parasite proteins enables selective therapies by targeting nucleophilic residues of macromolecules. We present the first covalent inhibitors of Leishmania braziliensis dihydroorotate dehydrogenase (LbDHODH), a key enzyme in pyrimidine biosynthesis with a reactive cysteine (Cys131) in its active site. From barbituric acid derivatives, we discovered 2i as a LbDHODH inhibitor with leishmanicidal activity, exhibiting an IC50 of 0.5 ± 0.1 μM, a Kinact/KI of 767 M-1s-1, no inhibition of the human ortholog, and an EC50 of 11 ± 5 μM in L. braziliensis promastigotes, with no cytotoxicity in THP-1 cells and good passive permeability. X-ray crystallography confirms covalent bond formation with Cys131 and reveals active-site rearrangements. These findings support the proposed covalent inhibition mechanism and provide structural insights for further optimization. Our study validates LbDHODH as a promising target for leishmaniasis therapy and highlights the potential of covalent inhibition in antiparasitic drug discovery.
- Open Access
- 16 April 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (16) , 16921-16937
Fragment Libraries from Large and Novel Synthetic Compounds and Natural Products: A Comparative Chemoinformatic Analysis
We report comprehensive fragment libraries obtained from large natural product databases and compare their chemical space coverage and diversity with those of synthetic fragment libraries. Specifically, we obtained 2,583,127 fragments derived from the recently updated collection of open natural product (COCONUT) data set with more than 695,133 unique (nonduplicate) natural products and 74,193 fragments derived from the Latin America Natural Product Database (LANaPDB) with 13,578 unique natural products from Latin America. The content, chemical space coverage, and chemical diversity of the natural product libraries were compared to the recently developed CRAFT library, which contains 1214 fragments based on distinct heterocyclic scaffolds and natural product-derived chemicals. The fragment libraries herein obtained and curated are freely available at https://github.com/DIFACQUIM/Fragment-libraries-from-large-synthetic-compounds-and-natural-products-collections.git.
- 16 April 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (16) , 16921-16937
Open AccessFragment Libraries from Large and Novel Synthetic Compounds and Natural Products: A Comparative Chemoinformatic Analysis
We report comprehensive fragment libraries obtained from large natural product databases and compare their chemical space coverage and diversity with those of synthetic fragment libraries. Specifically, we obtained 2,583,127 fragments derived from the recently updated collection of open natural product (COCONUT) data set with more than 695,133 unique (nonduplicate) natural products and 74,193 fragments derived from the Latin America Natural Product Database (LANaPDB) with 13,578 unique natural products from Latin America. The content, chemical space coverage, and chemical diversity of the natural product libraries were compared to the recently developed CRAFT library, which contains 1214 fragments based on distinct heterocyclic scaffolds and natural product-derived chemicals. The fragment libraries herein obtained and curated are freely available at https://github.com/DIFACQUIM/Fragment-libraries-from-large-synthetic-compounds-and-natural-products-collections.git.
- Open Access
- 6 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Fragment libraries from large synthetic compounds and natural products: A comparative chemoinformatic analysis
We report comprehensive fragment libraries obtained from large natural product databases and compare their chemical space coverage and diversity with synthetic fragment libraries. Specifically, we obtained 2,583,127 fragments derived from the recently updated Collection of Open Natural Products (COCONUT) data set with more than 695,133 non-redundant natural products, and 74,193 fragments derived from the Latin America Natural Product Database (LANaPDB) with 13,578 unique natural products from Latin America. The content, chemical space coverage and chemical diversity of the natural product libraries were compared to the recently developed CRAFT library, which contains 1,214 fragments based on novel heterocyclic scaffolds and natural product-derived chemicals. The fragments libraries herein obtained and curated are freely available at https://github.com/DIFACQUIM/Fragment-libraries-from-large-synthetic-compounds-and-natural-products-collections.git.
- 6 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFragment libraries from large synthetic compounds and natural products: A comparative chemoinformatic analysis
We report comprehensive fragment libraries obtained from large natural product databases and compare their chemical space coverage and diversity with synthetic fragment libraries. Specifically, we obtained 2,583,127 fragments derived from the recently updated Collection of Open Natural Products (COCONUT) data set with more than 695,133 non-redundant natural products, and 74,193 fragments derived from the Latin America Natural Product Database (LANaPDB) with 13,578 unique natural products from Latin America. The content, chemical space coverage and chemical diversity of the natural product libraries were compared to the recently developed CRAFT library, which contains 1,214 fragments based on novel heterocyclic scaffolds and natural product-derived chemicals. The fragments libraries herein obtained and curated are freely available at https://github.com/DIFACQUIM/Fragment-libraries-from-large-synthetic-compounds-and-natural-products-collections.git.
- Open Access
Synthetic Pathways to Pyrido[3,4-c]pyridazines and Their Polycyclic Derivatives
Pyrido[3,4-c]pyridazines are nitrogen-containing scaffolds that have been described as being promising in medicinal chemistry, but they are rather rare chemicals. In this review article, the literature on synthetic pathways towards pyrido[3,4-c]pyridazines is listed exhaustively, first with the bicyclic systems themselves that are obtained starting either from pyridines, pyridazines or other heterocycles. Then, the reports on the related tricyclic derivatives are discussed, again according to the source heterocycle, and finally we mention some examples on polycyclic systems.
Open AccessSynthetic Pathways to Pyrido[3,4-c]pyridazines and Their Polycyclic Derivatives
Pyrido[3,4-c]pyridazines are nitrogen-containing scaffolds that have been described as being promising in medicinal chemistry, but they are rather rare chemicals. In this review article, the literature on synthetic pathways towards pyrido[3,4-c]pyridazines is listed exhaustively, first with the bicyclic systems themselves that are obtained starting either from pyridines, pyridazines or other heterocycles. Then, the reports on the related tricyclic derivatives are discussed, again according to the source heterocycle, and finally we mention some examples on polycyclic systems.
- 11 January 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (5) , 2028-2032
2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction
Herein, a metal-free methodology towards 2-imidazolidinone benzofurans via piperazinone enaminoesters addition onto quinones and subsequent rearrangement has been disclosed.
- 11 January 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (5) , 2028-2032
2-Imidazolidinone benzofurans as unexpected outcome of the Lewis acid mediated Nenitzescu reaction
Herein, a metal-free methodology towards 2-imidazolidinone benzofurans via piperazinone enaminoesters addition onto quinones and subsequent rearrangement has been disclosed.